Authors:
McLeod, HL
Cassidy, J
Powrie, RH
Priest, DG
Zorbas, MA
Synold, TW
Shibata, S
Spicer, D
Bissett, D
Pithavala, YK
Collier, MA
Paradiso, LJ
Roberts, JD
Citation: Hl. Mcleod et al., Pharmacokinetic and pharmacodynamic evaluation of the glycinamide ribonucleotide formyltransferase inhibitor AG2034, CLIN CANC R, 6(7), 2000, pp. 2677-2684
Authors:
Roberts, JD
Shibata, S
Spicer, DV
McLeod, HL
Tombes, MB
Kyle, B
Carroll, M
Sheedy, B
Collier, MA
Pithavala, YK
Paradiso, LJ
Clendeninn, NJ
Citation: Jd. Roberts et al., Phase I study of AG2034, a targeted GARFT inhibitor, administered once every 3 weeks, CANC CHEMOT, 45(5), 2000, pp. 423-427
Authors:
Balch, OK
Collier, MA
DeBault, LE
Johnson, LL
Citation: Ok. Balch et al., Bioabsorbable suture anchor (co-polymer 85/15 D,L lactide/glycolide) implanted in bone: Correlation of physical/mechanical properties, magnetic resonance imaging, and histological response, ARTHROSCOPY, 15(7), 1999, pp. 691-708